Appointment to the Medicines Adverse Reactions Committee
Pursuant to section 8 of the Medicines Act 1981, the Director-General of Health has, as per their delegated authority, appointed to the Medicines Adverse Reactions Committee:
Professor Lianne Parkin
as the Director of the New Zealand Pharmacovigilance Centre (ex officio member) with a term of office commencing on 1 December 2024.
Dated at Wellington this 8th day of November 2024.
Dr DIANA SARFATI, Director-General of Health.